Market Research Report
In Vitro Toxicity Testing: Technologies and Global Markets
|In Vitro Toxicity Testing: Technologies and Global Markets|
Published: January 3, 2022
Content info: 228 Pages
Delivery time: 1-2 business days
The global in vitro toxicity testing market should reach $13.3 billion by 2026 from $9.0 billion in 2021 at a compound annual growth rate (CAGR) of 8.3% for the forecast period of 2021 to 2026.
The ADME segment of the global in vitro toxicity testing market is expected to grow from $2.6 billion in 2021 to $4.2 billion in 2026 at a CAGR of 9.8% for the forecast period of 2021 to 2026.
The cytotoxicity testing segment of the global in vitro toxicity testing market is expected to grow from $1.3 billion in 2021 to $2.0 billion in 2026 at a CAGR of 8.2% for the forecast period of 2021 to 2026.
This report examines the current and future market potential of In Vitro Toxicity Testing Technologies. It offers a detailed analysis of the competitive environment, the regulatory scenario, technological advancements, drivers, restraints, opportunity and trends in market growth. This report covers market projections through 2026 and market rank for key market players. The report details the market shares of In Vitro Toxicity Testing Technologies segmented by toxicity endpoints and tests, tools/technology, components and end users.
This report segments the global market by geographic region: North America, Europe, Asia-Pacific and the Rest of the world. The North American region includes the U.S., Canada and Mexico, the European region (including Germany, U.K., France and the Rest of Europe), the Asia-Pacific region (including China, India, Japan and the Rest of Asia-Pacific). For market estimates, data is provided for the year 2019-2020 as the base year and forecast through year-end, 2026.